Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (14)

2023

  1. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

    Nature Communications, Vol. 14, Núm. 1

  2. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

    The Lancet Diabetes and Endocrinology, Vol. 11, Núm. 1, pp. 33-41

2022

  1. Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

    Annals of the Rheumatic Diseases

2021

  1. Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

    European Journal of Pain (United Kingdom), Vol. 25, Núm. 7, pp. 1525-1539

2020

  1. A reference map of potential determinants for the human serum metabolome

    Nature, Vol. 588, Núm. 7836, pp. 135-140

  2. Subcutaneous tanezumab for osteoarthritis of the hip or knee: Efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 6, pp. 800-810

2019

  1. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

    Journal of Hepatology, Vol. 71, Núm. 3, pp. 594-602

2015

  1. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy Epidemiology of musculoskeletal disorders

    BMC Musculoskeletal Disorders, Vol. 16, Núm. 1

2011

  1. An approach to speed up the isolation of hydrophilic metabolites from natural sources at semipreparative level by using a hydrophilic-lipophilic balance/mixed-mode strong cation exchange-high-performance liquid chromatography/mass spectrometry system

    Journal of Chromatography A, Vol. 1218, Núm. 13, pp. 1790-1794

2007

  1. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

    Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225

  2. Vanchrobactin: absolute configuration and total synthesis

    Tetrahedron Letters, Vol. 48, Núm. 17, pp. 3021-3024

2006

  1. Isolation and synthesis of (-)-(5S)-2-Imino-1-methylpyrrolidine-5- carboxylic acid from cliona tenuis: Structure revision of pyrostatins

    Organic Letters, Vol. 8, Núm. 21, pp. 4967-4970

  2. Structural characterization of vanchrobactin, a new catechol siderophore produced by the fish pathogen Vibrio anguillarum serotype O2

    Tetrahedron Letters, Vol. 47, Núm. 39, pp. 7113-7116

2005

  1. Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: Final results of a phase II trial

    Clinical Breast Cancer, Vol. 6, Núm. 5, pp. 433-438